Occupational Therapists

  • STEP 1

    After you have logged in, navigate to the CPD Activities and Questionnaires tab where you will find the activities (as mentioned below) you have to complete.

    You will need 60 CEU’s for your audit to be compliant. A minimum of 10 CEU’s should be in the ethics category.

  • STEP 2

    Below is a list of all the activities available to complete.

    These cover a total of 76 CEU’s, and comprise 38 clinical, 17 ethics and 21 general CEU’s.

    1. If you already have a few CEU’s, complete any activities to make up for the CEU shortfall you need.


    1. If you currently have no CEU’s, complete any activities to make up for the 60 CEU’s you will need.


  • STEP 3

    When you have completed the necessary activities for your audit, please send an email or WhatsApp to notify us.

    (safocus@iafrica.com / 074 230 3874)

    We will confirm the correctness and then submit your CPD Individual Activity Record (IAR) on 29May2020 via email to the HPCSA and copy you in the email for your reference.

* Should you not finish before the 29th of May at 12h00 we will request for an extension on your behalf and send you an email with more details of the next steps.

Please contact us should you need more guidance.

  • OT1(20) – Effects of maternal views and support on childhood development through joint play
  • OT2(20) – Evidence Connection: Occupational therapy interventions – PART 1
  • OT2(20) – Occupational Therapy Interventions – Part 2
  • OT3(18) – Occupational Therapy Interventions for Adults with Musculoskeletal Conditions
  • OT3(20) – Embracing cultural diversity: Meaningful engagement for older adults with advanced dementia in a residential care setting
  • OT4(18) – Research Opportunities in the Area of Adults With Alzheimer’s Disease and Related Neurocognitive Disorders
  • OT4(20) – Promoting Healing with Therapeutic Use of Clay
  • OT5(20) – Use of the STAR PROCESS for Children with Sensory Processing Challenges
  • OT6(20) – The Impact of Cognitive Functioning on Daily Occupations for People with Multiple Sclerosis: A Qualitative Study
  • OT7(18) – Promoting Physical Activity and Nutrition in People with Stroke
  • OT7(20) – Gardening as a Meaningful Occupation in Initial Stroke Rehabilitation: An Occupational Therapist Perspective
  • OT8(18) – Occupational Therapy Interventions for Adults With Cancer
  • OT8(20) – Life After Losing an Adult Child to a Drug Overdose: A Kawa Perspective
  • OT9(18) – Promoting Health, Well-Being, and Quality of Life in Occupational Therapy: A Commitment to a Paradigm Shift for the Next 100 Years
  • OT9(20) – Examining clinical meaningfulness in randomized controlled trials: Revisiting the well elderly II
  • OT10(20) – National Institutes of Health research plan on rehabilitation / Research opportunities in the area of adults with Alzheimer’s disease and related neurocognitive disorders / Promoting physical activity and nutrition in people with stroke
  • PE1(20) Ethical guidelines on social media
  • PE1(19) – Advanced directives as a tool to respect patient’s values and preferences: discussion on the case of Alzheimer’s disease
  • PE2(19) – How technology impacts on the therapeutic relationship
  • PE3(20) – Digital pills: a scoping review of the empirical literature and analysis of the ethical aspects
  • PE5(20) – General ethical guidelines for good practice in telemedicine
  • G1(19) – Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting
  • G1(20) Human trafficking – what the health care professional can do
  • G2(20) – Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
  • G2a(19) Update of cannabis and its medical use  History and Pharmacology Part 1 of 3
  • G2b(19) Update of cannabis and its medical use  Cannabis toxicity and dependence Part 2 of 3
  • G2c(19) Update of cannabis and its medical use  The use of cannabis for medical purposes Part 3 of 3
  • G3(20) – The psychological impact of quarantine and how to reduce it: rapid review of the evidence
  • G5(20) – Clinical management of suspected or confirmed COVID-19 disease